University of Michigan Rogel Cancer Center clinical trials
Listed in the registry as: University, hospital or other organization.
The registry lists 322 studies whose lead sponsor is University of Michigan Rogel Cancer Center. 47 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 23, 2026.
Keep track of what changes. Save the University of Michigan Rogel Cancer Center studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesFocus areas
Conditions University of Michigan Rogel Cancer Center leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 322. Browse all 322 →
- Natalizumab for the Prevention of ICANS in Patients With Recurrent or Refractory Diffuse Large B-Cell Lymphoma or Mantle Cell Lymphoma Receiving CAR T-Cell TherapyRecruitingNCT07892027Phase 2
- A Pilot Study of Liver Protection Using Prednisone for Patients Receiving Stereotactic Body Radiation Therapy for Hepatocellular CarcinomaRecruitingNCT05901519Phase 2
- CIPN Decision Aid for the Improvement of Chemotherapy Decision Making in Patients With Breast CancerRecruitingNCT06915168Not applicable
- Urine Prostate Screening Integrated With MRI for Early Detection of Prostate Cancer, UPRISE TrialRecruitingNCT07526545Not applicable
- Personalized Cancer Support (Thrive Track) to Manage the Emotional Needs of Young Adults With Thyroid, Melanoma and Testicular Cancer, PerCS-YA TrialNot yet recruitingNCT07529080Not applicable
- Escalating Cycle 1 Dose of Lu-177-PSMA-617 for the Treatment of Metastatic Castration Resistant Prostate CancerNot yet recruitingNCT07682649Phase 1
- Office-Based Ureteroscopy Utilizing a Single Use Digital, Flexible Ureteroscope for Upper Tract Urothelial CarcinomaRecruitingNCT07630155Not applicable
- Pomalidomide After CAR T-cell Therapy for the Treatment of Relapsed or Refractory CD19+ B-cell Leukemia or LymphomaRecruitingNCT07532525Phase 1
- Transcranial Direct Current Stimulation for the Treatment of Chemotherapy-Induced Peripheral Neuropathy in Cancer SurvivorsRecruitingNCT07673614Not applicable
- An Artificial Intelligence-Powered Supportive Care Chatbot to Address the Supportive Care Needs of Young Adult Cancer SurvivorsRecruitingNCT07772596Not applicable
- Transcranial Direct Current Stimulation to Improve Gait for Breast Cancer Survivor's Who Received Taxene and/or Platinum ChemotherapyNot yet recruitingNCT07864792Not applicable
- Quantitative MRI for MyelofibrosisRecruitingNCT01973881
- Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid CancerRecruitingNCT03099356Phase 2
- Inulin Gel in Combination With Ipilimumab and Nivolumab for the Treatment of Metastatic or Locally Advanced Kidney Cell Cancer, ICON TrialRecruitingNCT06866262Phase 1/2
- Personalized Neck Radiation Therapy Directed by Sentinel Lymph Node Biopsy for the Treatment of Oral Cavity Squamous Cell Carcinoma, PRECEDENT TrialRecruitingNCT07121595Phase 2
- An Investigational Scan ([68Ga] Ga-FAPI-04 PET/CT) for the Imaging of Patients With High-Grade Neuroendocrine CancerRecruitingNCT07132645Early Phase 1
- Arsenic Trioxide to Prevent Relapse in Patients Undergoing Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia or Myelodysplastic SyndromeNot yet recruitingNCT07737769Phase 1
- SPECT/CT Imaging for Dosimetry in 177Lu-PSMA-617 (Pluvicto) TherapyRecruitingNCT07096999
- Phase II Study of Resistant Potato Starch Plus Deferasirox to Improve Outcomes in Patients Undergoing Allogeneic Stem Cell TransplantationRecruitingNCT06784336Phase 2
- Study of Neoadjuvant Enfortumab Vedotin and Pembrolizumab in Upper Tract Urothelial CancerRecruitingNCT06356155Phase 2
- Solution-Focused Brief Therapy for Support of Psychological Distress in Adolescent and Young Adult Cancer SurvivorsRecruitingNCT06941324Not applicable
- Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With CancerRecruitingNCT05183126Phase 4
- Localized Leiomyosarcoma Biomarker ProtocolRecruitingNCT04925089
- Gilteritinib for the Treatment of ALK NSCLCRecruitingNCT06225427Phase 1
- Ivonescimab Before Surgery for the Treatment of Resectable Stage II-IV Head and Neck CancerRecruitingNCT07094685Phase 2
- A Virtually Delivered Diet Intervention (LASO-3) for the Improvement of Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors Post-treatmentRecruitingNCT07365007Not applicable
- Metastatic Leiomyosarcoma Biomarker ProtocolRecruitingNCT05653388
- Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal Women With Breast Cancer, OFS TrialRecruitingNCT07158021Phase 2
- Virus-Based Gene Therapy (AdV-HSV1-TK and AdV-Flt3L) in Combination With Valacyclovir for the Treatment of Pediatric and Young Adult Patients With Resectable, Recurrent Primary Malignant Brain TumorsRecruitingNCT06914479Phase 1
- Navigation Interventions to Improve Cascade Genetic Testing Among Relatives of Patients With Hereditary Cancer SyndromesRecruitingNCT06927947Not applicable
- Targeted Early Detection Program in Men at High Genetic Risk for Prostate CancerRecruitingNCT07645391
- Trial of Exercise Therapy in Familial Adenomatous Polyp (FAP)RecruitingNCT06641310Not applicable
- A Web-Based Program (Kindred) to Improve the Understanding of Genetic Cancer Risk and Cancer Genetic Testing in African American FamiliesNot yet recruitingNCT07542405Not applicable
- Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and AdenomasRecruitingNCT00843375
- Pembrolizumab and Mogamulizumab in Advanced-stage, Relapsed/Refractory Cutaneous T-cell LymphomasRecruitingNCT05956041Phase 2
- Ruxolitinib and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate CancerRecruitingNCT06616155Phase 1/2
- Prehabilitation Program to Improve Cardiac Reserve in High-Risk Patients Undergoing Hematopoietic Stem Cell TransplantationRecruitingNCT05945121Not applicable
- SunBeast: Evaluating UV Protective Behaviors and Education Interventions Among UltrarunnersNot yet recruitingNCT07481344Not applicable
- A Dietary Supplement (Resistant Potato Starch) for Reducing Musculoskeletal Symptoms in Individuals Planning to Receive Aromatase Inhibitor Therapy, AIMSS-RPS TrialRecruitingNCT07443943Phase 2
- Breast Cancer Resiliency Through Exercise Program (B-REP)RecruitingNCT06100263Not applicable
- A Phase II Study for p16+ Oropharyngeal Cancer PerSonalized De-escalation Treatment at University of MIchigan (CuSToMIze)RecruitingNCT05894083Phase 2
- Pacritinib in Relapsed/Refractory T-cell Lymphoproliferative NeoplasmsRecruitingNCT04858256Phase 2
- A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer PatientsRecruitingNCT07291414Not applicable
- Post-prostatectomy Radiation Therapy--Moderate Versus Ultra-hypofractionated (Also Known as Stereotactic Body Radiation Therapy [SBRT])RecruitingNCT05038332Phase 2
- Interstitial Assessment of Architectural Heterogeneity in Prostate Cancer Using a Fine Needle Photoacoustic ProbeRecruitingNCT05965180
- Living Well With LymphomaRecruitingNCT06047626Not applicable
- Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant RecipientsRecruitingNCT05866302
- Study of Ribociclib Administered Concurrently With Postoperative Radiation Therapy in Patients With High-Risk, HR+/HER2- Breast CancerActive, not recruitingNCT05996107Phase 1
- Combined Y-90 Selective Internal Radiation Therapy (Y-90 SIRT) and Stereotactic Body Radiation Therapy (SBRT) in Hepatic Malignancy.Active, not recruitingNCT04518748Not applicable
- Genomics in Michigan to AdJust Outcomes in Prostate canceR (G-MAJOR) for Men With Newly Diagnosed Favorable Risk Prostate CancerActive, not recruitingNCT04396808Not applicable